Neuroparticle Advances to Final Round

We are happy to announce that NeuroParticle passed the rigorous elimination and advanced to the final round of the Second Salisbury Award Competition for the Entrepreneurial Translational Research held by the National Foundation for Cancer Research (NFCR).

“The Salisbury Award encourages and promotes innovative scientists and early stage start-up companies to translate their discoveries into therapies that can improve the lives of cancer patients. Its establishment honors the Salisbury family’s vision and legacy of funding ‘high risk, high impact and high reward’ cancer research.”

National Foundation for Cancer Research Conducts Salisbury Award Competition